Glowing dye could light up hidden lymph nodes in prostate cancer surgery
NCT ID NCT02119858
First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time
Summary
This trial tests whether a dye called indocyanine green, viewed with near-infrared imaging, can help surgeons spot pelvic lymph nodes during robot-assisted prostate removal in men with stage II prostate cancer. The dye is injected into the prostate, and the imaging system is used during surgery to see if the lymph nodes light up. The goal is to improve the accuracy of lymph node removal, which may lead to better cancer staging and treatment planning.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- indocyanine green solution (a dye) used with near-infrared imaging during robot-assisted prostate surgery
- What this could lead to
- If it works, this could make lymph node removal during prostate cancer surgery more accurate, potentially improving staging and treatment decisions.
- What could go wrong
- This is a small early-phase trial, so results may not apply broadly. The dye or imaging might not clearly improve detection, and surgery carries standard risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IIA PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a depression drug fight prostate cancer?
- Glow-in-the-Dark antibody could help surgeons spot prostate cancer
- Black raspberries under the microscope for prostate cancer prevention
- New radiation approach aims to tame prostate cancer with fewer side effects
- Triple therapy shows promise for aggressive prostate cancer
- New radiation approach aims to safely target returning prostate cancer